Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease

Journal of Pediatrics

Volumn 163, Issue 2, 2013, Pages

  Kobayashi, Tohru ^a,b   Kobayashi, Tomio ^c   Morikawa, Akihiro ^a,d   Ikeda, Kentaro ^a   Seki, Mitsuru ^c   Shimoyama, Shinya ^c   Ishii, Yoichiro ^c   Suzuki, Takahiro ^e   Nakajima, Kimiko ^c   Sakamoto, Naoko ^f   Arakawa, Hirokazu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Gunma Children's Medical Center   (Japan)

^d Kitakanto Allergy Institute   (Japan)

^e SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^f NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

C reactive protein; CAA; Coronary artery abnormality; CRP; IL; Interleukin; Intravenous immunoglobulin; IVIG; Kawasaki disease; KD; Methylprednisolone; mPSL

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; PREDNISOLONE SODIUM SUCCINATE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CORONARY ARTERY ANOMALY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT RESPONSE;

EID: 84880602888     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.01.022     Document Type: Article

References (29)

1. J.C. Burns, and M.P. Glode Kawasaki syndrome Lancet 364 2004 533 544
2. K. Furusho, K. Sato, T. Soeda, H. Matsumoto, T. Okabe, and T. Hirota High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 1984 1055 1058
3. J.W. Newburger, M. Takahashi, J.C. Burns, A.S. Beiser, K.J. Chung, and C.E. Duffy Treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 1986 341 347
4. J.W. Newburger, M. Takahashi, A.S. Beiser, J.C. Burns, J. Bastian, and K.J. Chung Single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 324 1991 1633 1639
5. C.A. Wallace, J.W. French, S.J. Kahn, and D.D. Sherry Initial intravenous gamma globulin treatment failure in Kawasaki disease Pediatrics 105 2000 e78
6. K. Durongpisitkul, J. Soongswang, D. Laohaprasitiporn, A. Nana, C. Prachuabmoh, and C. Kangkagate Immunoglobulin failure and retreatment in Kawasaki disease Pediatr Cardiol 24 2003 145 148
7. J.C. Burns, E.V. Capparelli, J.A. Brown, J.W. Newburger, and M.P. Glode Intravenous gamma-globulin treatment and retreatment in Kawasaki disease Pediatr Infect Dis J 17 1998 1144 1148
8. M. Miura, K. Kohno, H. Ohki, S. Yoshiba, A. Sugaya, and M. Satoh Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin Eur J Pediatr 167 2008 1119 1123
9. T. Furukawa, M. Kishiro, K. Akimoto, S. Nagata, T. Shimizu, and Y. Yamashiro Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease Arch Dis Child 93 2008 142 146
10. B.A. Lang, R.S. Yeung, K.G. Oen, P.N. Malleson, A.M. Huber, and M. Riley Corticosteroid treatment of refractory Kawasaki disease J Rheumatol 33 2006 803 809
11. H. Suzuki, M. Terai, H. Hamada, T. Honda, T. Suenaga, and T. Takeuchi Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin Pediatr Infect Dis J 30 2011 871 876
12. T.J. Lee, K.H. Kim, J.K. Chun, and D.S. Kim Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease Yonsei Med J 49 2008 714 718
13. J.C. Burns, B.M. Best, A. Mejias, L. Mahony, D.E. Fixler, and H.S. Jafri Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease J Pediatr 153 2008 833 838
14. T. Saji, and Y. Kemmotsu Infliximab for Kawasaki syndrome J Pediatr 149 2006 426
15. M.B. Son, K. Gauvreau, J.C. Burns, E. Corinaldesi, A.H. Tremoulet, and V.E. Watson Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study J Pediatr 158 2011 644 649.e1
16. M. Mori, T. Imagawa, S. Katakura, T. Miyamae, K. Okuyama, and S. Ito Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin Mod Rheumatol 14 2004 43 47
17. J.W. Newburger, M. Takahashi, M.A. Gerber, M.H. Gewitz, L.Y. Tani, and J.C. Burns Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 2004 2747 2771
18. M. Ayusawa, T. Sonobe, S. Uemura, S. Ogawa, Y. Nakamura, and N. Kiyosawa Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) Pediatr Int 47 2005 232 234
19. T. Kobayashi, Y. Inoue, K. Takeuchi, Y. Okada, K. Tamura, and T. Tomomasa Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease Circulation 113 2006 2606 2612
20. T. Kobayashi, T. Saji, T. Otani, K. Takeuchi, T. Nakamura, and H. Arakawa Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial Lancet 379 2012 1613 1620
21. Y. Okada, M. Shinohara, T. Kobayashi, Y. Inoue, T. Tomomasa, and T. Kobayashi Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children J Pediatr 143 2003 363 367
22. H. Makata, T. Ichiyama, R. Uchi, T. Takekawa, T. Matsubara, and S. Furukawa Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease Naunyn Schmiedebergs Arch Pharmacol 373 2006 325 332
23. S. Ogata, Y. Ogihara, K. Nomoto, K. Akiyama, Y. Nakahata, and K. Sato Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone Pediatr Res 66 2009 577 584
24. K. Egami, H. Muta, M. Ishii, K. Suda, Y. Sugahara, and M. Iemura Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease J Pediatr 149 2006 237 240
25. A.H. Rowley, C.A. Eckerley, H.M. Jack, S.T. Shulman, and S.C. Baker IgA plasma cells in vascular tissue of patients with Kawasaki disease J Immunol 159 1997 5946 5955
26. A.H. Rowley, S.T. Shulman, B.T. Spike, C.A. Mask, and S.C. Baker Oligoclonal IgA response in the vascular wall in acute Kawasaki disease J Immunol 166 2001 1334 1343
27. T.J. Brown, S.E. Crawford, M.I. Cornwall, F. Garcia, S.T. Shulman, and A.H. Rowley CD8 T lymphocytosis and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease J Infect Dis 184 2001 940 943
28. K. Millar, C. Manlhiot, R.S. Yeung, Z. Somji, and B.W. McCrindle Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression Int J Cardiol 154 2012 9 13
29. M. Miura, T. Tamame, T. Naganuma, S. Chinen, M. Matsuoka, and H. Ohki Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapy Pediatr Child Health 16 2011 479 484